Details
Stereochemistry | RACEMIC |
Molecular Formula | C22H22N2O6 |
Molecular Weight | 410.4199 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(OC)=NC(OC(C(O)=O)C(OC)(C2=CC=CC=C2)C3=CC=CC=C3)=N1
InChI
InChIKey=FEJVSJIALLTFRP-UHFFFAOYSA-N
InChI=1S/C22H22N2O6/c1-27-17-14-18(28-2)24-21(23-17)30-19(20(25)26)22(29-3,15-10-6-4-7-11-15)16-12-8-5-9-13-16/h4-14,19H,1-3H3,(H,25,26)
Molecular Formula | C22H22N2O6 |
Molecular Weight | 410.4199 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/20725142
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20725142
Darusentan is a mixture of two isomers R and S, the last enantiomer is responsible for the therapeutic properties.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:00:04 GMT 2023
by
admin
on
Sat Dec 16 10:00:04 GMT 2023
|
Record UNII |
UAG0ANS9HZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9953358
Created by
admin on Sat Dec 16 10:00:04 GMT 2023 , Edited by admin on Sat Dec 16 10:00:04 GMT 2023
|
PRIMARY | |||
|
178306-46-2
Created by
admin on Sat Dec 16 10:00:04 GMT 2023 , Edited by admin on Sat Dec 16 10:00:04 GMT 2023
|
PRIMARY | |||
|
m4100
Created by
admin on Sat Dec 16 10:00:04 GMT 2023 , Edited by admin on Sat Dec 16 10:00:04 GMT 2023
|
PRIMARY | Merck Index | ||
|
UAG0ANS9HZ
Created by
admin on Sat Dec 16 10:00:04 GMT 2023 , Edited by admin on Sat Dec 16 10:00:04 GMT 2023
|
PRIMARY |